BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 20615202)

  • 1. Miniaturized FISH for screening of onco-hematological malignancies.
    Zanardi A; Bandiera D; Bertolini F; Corsini CA; Gregato G; Milani P; Barborini E; Carbone R
    Biotechniques; 2010 Jul; 49(1):497-504. PubMed ID: 20615202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FISH panels for hematologic malignancies.
    Sreekantaiah C
    Cytogenet Genome Res; 2007; 118(2-4):284-96. PubMed ID: 18000382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of numerical aberrations in hematologic neoplasias by fluorescence in situ hybridization.
    Cuneo A; Bigoni R; Roberti MG; Bardi A; Balsamo R; Piva N; Castoldi G
    Haematologica; 1997; 82(1):85-90. PubMed ID: 9107092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Automatic quantification of gene amplification in clinical samples by IQ-FISH.
    Narath R; Lörch T; Rudas M; Ambros PF
    Cytometry B Clin Cytom; 2004 Jan; 57(1):15-22. PubMed ID: 14696059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FISH analysis of native smears from bone marrow and blood for the monitoring of chimerism and clonal markers after stem cell transplantation in children.
    Fuehrer M; Gerusel-Bleck M; Konstantopoulos N; Bender-Goetze C; Walther JU
    Int J Mol Med; 2005 Feb; 15(2):291-7. PubMed ID: 15647846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluorescent in situ hybridization (FISH) in bone marrow and peripheral blood of leukemia patients: implications for occupational surveillance.
    McDevitt MA; Condon M; Stamberg J; Karp JE; McDiarmid M
    Mutat Res; 2007 Apr; 629(1):24-31. PubMed ID: 17276720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in fluorescence in situ hybridization (FISH) in hematology.
    Berger R
    Pathol Biol (Paris); 1995 Mar; 43(3):175-80. PubMed ID: 7675544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for NUP98 rearrangements in hematopoietic malignancies by fluorescence in situ hybridization.
    Nebral K; König M; Schmidt HH; Lutz D; Sperr WR; Kalwak K; Brugger S; Dworzak MN; Haas OA; Strehl S
    Haematologica; 2005 Jun; 90(6):746-52. PubMed ID: 15951287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chromosome analysis and FISH method].
    Eguchi M; Tanaka K
    Rinsho Byori; 1996 Jun; 44(6):541-7. PubMed ID: 8752732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metaphase FISH, microdissection, and multicolour FISH. Applications in haematology.
    Mecucci C; Falzetti D; La Starza R
    Haematologica; 1999 Jun; 84 Suppl EHA-4():98-101. PubMed ID: 10907483
    [No Abstract]   [Full Text] [Related]  

  • 11. [Diagnosis of aneuploidy with fluorescence in situ hybridization (FISH); value in pregnancies with increased risk for chromosome aberrations].
    Ulmer R; Pfeiffer RA; Kollert A; Beinder E
    Z Geburtshilfe Neonatol; 2000; 204(1):1-7. PubMed ID: 10721179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of bone marrow involvement in malignant lymphoma using fluorescence in situ hybridization: possible utility in the detection of micrometastasis.
    Huh HJ; Min HC; Cho HI; Chae SL; Lee DS
    Cancer Genet Cytogenet; 2008 Oct; 186(1):1-5. PubMed ID: 18786435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of new translocations involving ETV6 in hematologic malignancies by fluorescence in situ hybridization and spectral karyotyping.
    Odero MD; Carlson K; Calasanz MJ; Lahortiga I; Chinwalla V; Rowley JD
    Genes Chromosomes Cancer; 2001 Jun; 31(2):134-42. PubMed ID: 11319801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorescence in situ hybridization (FISH) in cytogenetics of leukemia.
    Michalová K
    Folia Biol (Praha); 1996; 42(6):311-4. PubMed ID: 9158941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of trisomy 12 by fluorescence in situ hybridization in peripheral blood, bone marrow and lymph nodes of patients with B-cell chronic lymphocytic leukemia.
    Liso V; Capalbo S; Lapietra A; Pavone V; Guarini A; Specchia G
    Haematologica; 1999 Mar; 84(3):212-7. PubMed ID: 10189384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of del(20q) in patients with hematological malignancies.
    Brezinová J; Zemanová Z; Ransdorfová S; Sindelárová L; Sisková M; Neuwirtová R; Cermák J; Michalová K
    Cancer Genet Cytogenet; 2005 Jul; 160(2):188-92. PubMed ID: 15993278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous detection of multiple genetic aberrations in single cells by spectral fluorescence in situ hybridization.
    Slovak ML; Tcheurekdjian L; Zhang FF; Murata-Collins JL
    Cancer Res; 2001 Feb; 61(3):831-6. PubMed ID: 11221864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of fluorescence in situ hybridization (FISH) for monitoring hematologic malignancies with BCR/ABL or ETO/AML1 rearrangement: a comparative study with FISH and G-banding on 919 consecutive specimens of hematologic malignancies.
    Lee DY; Cho HI; Kang YH; Yun SS; Park SY; Lee YS; Kim Y; Lee DS
    Cancer Genet Cytogenet; 2004 Jul; 152(1):1-7. PubMed ID: 15193435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interphase cytogenetics of hematological neoplasms under the perspective of the novel WHO classification.
    Martín-Subero JI; Gesk S; Harder L; Grote W; Siebert R
    Anticancer Res; 2003; 23(2A):1139-48. PubMed ID: 12820362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of chromosome 13 deletions by fluorescent in situ hybridization.
    VanWier S; Fonseca R
    Methods Mol Med; 2005; 113():59-69. PubMed ID: 15968095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.